Cancer Research: Cross-Literature Analysis and Ferroptosis Simulation

Open-source cancer research combining cross-literature analysis of 4,830 PubMed-indexed research articles with Monte Carlo biochemical simulations of ferroptosis sensitivity across cell phenotypes, drug combinations, and tumor microenvironment features. This archive contains the complete analysis pipeline (Python), simulation engine (Rust, ferroptosis-core library with 10 binaries and 31 unit tests), a 112-page book-format manuscript with 20 figures, and corpus metadata for reconstruction from PubMed. The simulations explore how physical ROS-generating modalities (sonodynamic therapy, photodynamic therapy) compare to pharmacologic ferroptosis inducers (RSL3) under realistic tumor conditions including hypoxia, stromal shielding, acidic pH, and immune coupling. Key findings include: (1) RSL3 + FSP1 inhibitor produces 1.99x Bliss synergy through dual-pathway depletion, (2) the tumor microenvironment selectively penalizes pharmacologic ferroptosis inducers through three resistance mechanisms while leaving physical modalities unaffected, and (3) tissue-specific drug penetration creates a substantial in-vitro-to-in-vivo translation gap. All findings are model-predicted with documented assumptions, sensitivity analyses, and proposed experimental validations. Full-text corpus articles are excluded from this deposit for licensing reasons (61 of 4,830 have unconfirmed open-access status). The corpus metadata index (INDEX.jsonl) provides PMIDs, mechanisms, cancer types, and evidence tiers for reconstruction via PubMed. Content classes: MIT-licensed code, author-owned manuscript, non-copyrightable abstracts and metadata. See PROVENANCE.yaml for full asset licensing details.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-04-26
DOI
https://doi.org/10.5281/zenodo.19777191
Primary Topic
Ferroptosis and cancer prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cancer Research: Cross-Literature Analysis and Ferroptosis Simulation

Zeke Lares
Zenodo (CERN European Organization for Nuclear Research)
Ferroptosis and cancer prognosis
article

Cancer Research: Cross-Literature Analysis and Ferroptosis Simulation

Zeke Lares
article en

Abstract

Open-source cancer research combining cross-literature analysis of 4,830 PubMed-indexed research articles with Monte Carlo biochemical simulations of ferroptosis sensitivity across cell phenotypes, drug combinations, and tumor microenvironment features. This archive contains the complete analysis pipeline (Python), simulation engine (Rust, ferroptosis-core library with 10 binaries and 31 unit tests), a 112-page book-format manuscript with 20 figures, and corpus metadata for reconstruction from PubMed. The simulations explore how physical ROS-generating modalities (sonodynamic therapy, photodynamic therapy) compare to pharmacologic ferroptosis inducers (RSL3) under realistic tumor conditions including hypoxia, stromal shielding, acidic pH, and immune coupling. Key findings include: (1) RSL3 + FSP1 inhibitor produces 1.99x Bliss synergy through dual-pathway depletion, (2) the tumor microenvironment selectively penalizes pharmacologic ferroptosis inducers through three resistance mechanisms while leaving physical modalities unaffected, and (3) tissue-specific drug penetration creates a substantial in-vitro-to-in-vivo translation gap. All findings are model-predicted with documented assumptions, sensitivity analyses, and proposed experimental validations. Full-text corpus articles are excluded from this deposit for licensing reasons (61 of 4,830 have unconfirmed open-access status). The corpus metadata index (INDEX.jsonl) provides PMIDs, mechanisms, cancer types, and evidence tiers for reconstruction via PubMed. Content classes: MIT-licensed code, author-owned manuscript, non-copyrightable abstracts and metadata. See PROVENANCE.yaml for full asset licensing details.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 7%
Ferroptosis and cancer prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.